LSD1 &8211mediated FOXA2/AP1 transcription program drives lineage plasticity in prostate cancer

被引:0
|
作者
Wang, Zifeng
Liu, Mingyu
Zhang, Songqi
Li, Muqing
Patalano, Susan
Macoska, Jill A.
Han, Dong
Gao, Shuai
He, Hansen
Cai, Changmeng
机构
关键词
D O I
10.1158/1538-7445.AM2023-4753
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
4753
引用
收藏
页数:2
相关论文
共 50 条
  • [41] MAOA Drives Anti Androgen Therapy Resistance in Advanced Prostate Cancer by Conferring Neuroendocrine Plasticity via a Twist1 BRN2 Signaling Pathway
    Wei, Jing
    Wang, Jing
    Chen, Chia-hui
    Guan, Wen
    Wu, Boyang
    CANCER RESEARCH, 2024, 84 (06)
  • [42] Downregulation of Homologous Recombination DNA Repair Genes by HDAC Inhibition in Prostate Cancer Is Mediated through the E2F1 Transcription Factor
    Kachhap, Sushant K.
    Rosmus, Nadine
    Collis, Spencer J.
    Kortenhorst, Madeleine S. Q.
    Wissing, Michel D.
    Hedayati, Mohammad
    Shabbeer, Shabana
    Mendonca, Janet
    Deangelis, Justin
    Marchionni, Luigi
    Lin, Jianqing
    Hoti, Naseruddin
    Nortier, Johan W. R.
    DeWeese, Theodore L.
    Hammers, Hans
    Carducci, Michael A.
    PLOS ONE, 2010, 5 (06):
  • [43] Hes6 drives a critical androgen receptor (AR) transcriptional program to induce castration resistant prostate cancer (CRPC) through activation of an E2F1-mediated cell cycle network
    Lamb, A. D.
    Ramos-Montoya, A.
    Russell, R.
    Carroll, T.
    Massie, C.
    Shaw, G.
    Sharma, N. L.
    Warren, A. Y.
    Wooster, R. F.
    Mills, I. G.
    Neal, D. E.
    BJU INTERNATIONAL, 2014, 113 : 9 - 9
  • [44] Regulation of Nrf2-and AP-1-mediated gene expression by epigallocatechin-3-gallate and sulforaphane in prostate of Nrf2-knockout or C57BL/6J mice and PC-3 AP-1 human prostate cancer cells
    Nair, Sujit
    Barve, Avantika
    Khor, Tin-Oo
    Shen, Guo-xiang
    Lin, Wen
    Chan, Jefferson Y.
    Cai, Li
    Kong, Ah-Ng
    ACTA PHARMACOLOGICA SINICA, 2010, 31 (09) : 1223 - 1240
  • [45] Regulation of Nrf2- and AP-1-mediated gene expression by epigallocatechin-3-gallate and sulforaphane in prostate of Nrf2-knockout or C57BL/6J mice and PC-3 AP-1 human prostate cancer cells
    Sujit Nair
    Avantika Barve
    Tin-Oo Khor
    Guo-xiang Shen
    Wen Lin
    Jefferson Y Chan
    Li Cai
    Ah-Ng Kong
    Acta Pharmacologica Sinica, 2010, 31 : 1223 - 1240
  • [46] WDR3 promotes stem cell-like properties in prostate cancer by inhibiting USF2-mediated transcription of RASSF1A
    Liu, Weijing
    Xie, An
    Xiong, Jing
    Li, Sheng
    Yang, Lin
    Liu, Weipeng
    JOURNAL OF GENE MEDICINE, 2023, 25 (07):
  • [47] Long non-coding RNA LINC01133 represses KLF2, P21 and E-cadherin transcription through binding with EZH2, LSD1 in non small cell lung cancer
    Zang, Chongshuang
    Nie, Feng-qi
    Wang, Qian
    Sun, Ming
    Li, Wei
    He, Jing
    Zhang, Meiling
    Lu, Kai-hua
    ONCOTARGET, 2016, 7 (10) : 11696 - 11707
  • [48] Indirubin-3′-monoxime Inhibits AP-1-Mediated Matrix Metalloproteinas-9 in LNCaP Prostate Cancer Cells by Activating the Nrf2/HO-1 Signaling Pathway
    Dilshara, Matharage G.
    Molagoda, Ilandarage M. N.
    Jayasooriya, Rajapaksha G. P. T.
    Choi, Yung H.
    Park, Cheol
    Lee, Seunghun
    Kim, Gi-Young
    LATIN AMERICAN JOURNAL OF PHARMACY, 2020, 39 (02): : 269 - 278
  • [49] Procyanidin B2 3,3''-di-O-gallate, a Biologically Active Constituent of Grape Seed Extract, Induces Apoptosis in Human Prostate Cancer Cells Via Targeting NF-kB, Stat3, and AP1 Transcription Factors
    Tyagi, Alpna
    Raina, Komal
    Shrestha, Suraj Prakash
    Miller, Bettina
    Thompson, John A.
    Wempe, Michael F.
    Agarwal, Rajesh
    Agarwal, Chapla
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2014, 66 (04): : 736 - 746
  • [50] AP-1-mediated chromatin looping regulates ZEB2 transcription: new insights into TNFα-induced epithelial-mesenchymal transition in triple-negative breast cancer
    Qiao, Yichun
    Shiue, Chiou-Nan
    Zhu, Jian
    Zhuang, Ting
    Jonsson, Philip
    Wright, Anthony P. H.
    Zhao, Chunyan
    Dahlman-Wright, Karin
    ONCOTARGET, 2015, 6 (10) : 7804 - 7814